 | • レポートコード：D0GIR-02795 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、注意欠陥・多動性障害（ADHD）の世界市場を広く調査・分析し、今後の市場展望をまとめております。注意欠陥・多動性障害（ADHD）の種類別市場規模（覚醒剤、非覚醒剤）、用途別市場規模（専門クリニック、病院、小売）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Takeda、Novartis、Pfizer、Neos Therapeutics、Noven Pharmaceuticals、Eli Lilly、Curemark、Supernus Pharmaceuticals、Alcobra、Johnson & Johnson ・地域別グローバル市場分析 2015年-2020年 ・注意欠陥・多動性障害（ADHD）の北米市場（アメリカ、カナダ、メキシコ） ・注意欠陥・多動性障害（ADHD）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・注意欠陥・多動性障害（ADHD）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・注意欠陥・多動性障害（ADHD）の南米市場（ブラジル、アルゼンチン） ・注意欠陥・多動性障害（ADHD）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：覚醒剤、非覚醒剤 ・用途別分析：専門クリニック、病院、小売 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Attention Deficit Hyperactivity Disorder (ADHD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 16900 million by 2025, from USD 14740 million in 2019.
The Attention Deficit Hyperactivity Disorder (ADHD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Attention Deficit Hyperactivity Disorder (ADHD) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Attention Deficit Hyperactivity Disorder (ADHD) market has been segmented into:
Stimulants
Non-Stimulants
By Application, Attention Deficit Hyperactivity Disorder (ADHD) has been segmented into:
Specialty Clinics
Hospital
Retail
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Attention Deficit Hyperactivity Disorder (ADHD) market presented in the report. This section sheds light on the sales growth of different regional and country-level Attention Deficit Hyperactivity Disorder (ADHD) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Attention Deficit Hyperactivity Disorder (ADHD) market.
The report offers in-depth assessment of the growth and other aspects of the Attention Deficit Hyperactivity Disorder (ADHD) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Attention Deficit Hyperactivity Disorder (ADHD) Market Share Analysis
Attention Deficit Hyperactivity Disorder (ADHD) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Attention Deficit Hyperactivity Disorder (ADHD) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Attention Deficit Hyperactivity Disorder (ADHD) sales, revenue and market share for each player covered in this report.
The major players covered in Attention Deficit Hyperactivity Disorder (ADHD) are:
Takeda
Novartis
Pfizer
Neos Therapeutics
Noven Pharmaceuticals
Eli Lilly
Curemark
Supernus Pharmaceuticals
Alcobra
Johnson & Johnson
Table of Contents
1 Attention Deficit Hyperactivity Disorder (ADHD) Market Overview
1.1 Product Overview and Scope of Attention Deficit Hyperactivity Disorder (ADHD)
1.2 Classification of Attention Deficit Hyperactivity Disorder (ADHD) by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type in 2019
1.2.3 Stimulants
1.2.4 Non-Stimulants
1.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Market by Application
1.3.1 Overview: Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Specialty Clinics
1.3.3 Hospital
1.3.4 Retail
1.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market by Regions
1.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Attention Deficit Hyperactivity Disorder (ADHD) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takeda SWOT Analysis
2.1.4 Takeda Product and Services
2.1.5 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Neos Therapeutics
2.4.1 Neos Therapeutics Details
2.4.2 Neos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Neos Therapeutics SWOT Analysis
2.4.4 Neos Therapeutics Product and Services
2.4.5 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Noven Pharmaceuticals
2.5.1 Noven Pharmaceuticals Details
2.5.2 Noven Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Noven Pharmaceuticals SWOT Analysis
2.5.4 Noven Pharmaceuticals Product and Services
2.5.5 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly SWOT Analysis
2.6.4 Eli Lilly Product and Services
2.6.5 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Curemark
2.7.1 Curemark Details
2.7.2 Curemark Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Curemark SWOT Analysis
2.7.4 Curemark Product and Services
2.7.5 Curemark Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Supernus Pharmaceuticals
2.8.1 Supernus Pharmaceuticals Details
2.8.2 Supernus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Supernus Pharmaceuticals SWOT Analysis
2.8.4 Supernus Pharmaceuticals Product and Services
2.8.5 Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Alcobra
2.9.1 Alcobra Details
2.9.2 Alcobra Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Alcobra SWOT Analysis
2.9.4 Alcobra Product and Services
2.9.5 Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Johnson & Johnson SWOT Analysis
2.10.4 Johnson & Johnson Product and Services
2.10.5 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share
3.2.2 Top 10 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Market Share by Regions
4.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
4.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
4.5 South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
5 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries
5.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2015-2020)
5.2 USA Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
5.3 Canada Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
5.4 Mexico Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
6 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries
6.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2015-2020)
6.2 Germany Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
6.3 UK Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
6.4 France Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
6.5 Russia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
6.6 Italy Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries
7.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2015-2020)
7.2 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
7.3 Japan Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
7.4 Korea Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
7.5 India Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
8 South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries
8.1 South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2015-2020)
8.2 Brazil Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
8.3 Argentina Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Attention Deficit Hyperactivity Disorder (ADHD) by Countries
9.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
9.3 UAE Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
9.4 Egypt Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
9.5 South Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Market Share by Type (2015-2020)
10.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Type (2019-2024)
10.3 Stimulants Revenue Growth Rate (2015-2025)
10.4 Non-Stimulants Revenue Growth Rate (2015-2025)
11 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Segment by Application
11.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Application (2015-2020)
11.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Application (2019-2024)
11.3 Specialty Clinics Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
11.5 Retail Revenue Growth (2015-2020)
12 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Forecast (2021-2025)
12.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Forecast (2021-2025)
12.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Regions (2021-2025)
12.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
12.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
12.6 South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Attention Deficit Hyperactivity Disorder (ADHD) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Takeda Corporate Information, Location and Competitors
Table 6. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 7. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 8. Takeda SWOT Analysis
Table 9. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 10. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 13. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 16. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 19. Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 22. Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Neos Therapeutics Corporate Information, Location and Competitors
Table 24. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 25. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 26. Neos Therapeutics SWOT Analysis
Table 27. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 28. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Noven Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 31. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 32. Noven Pharmaceuticals SWOT Analysis
Table 33. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 34. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eli Lilly Corporate Information, Location and Competitors
Table 36. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 37. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 38. Eli Lilly SWOT Analysis
Table 39. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 40. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Curemark Corporate Information, Location and Competitors
Table 42. Curemark Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 43. Curemark Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 44. Curemark SWOT Analysis
Table 45. Curemark Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 46. Curemark Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Supernus Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 49. Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 50. Supernus Pharmaceuticals SWOT Analysis
Table 51. Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 52. Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Alcobra Corporate Information, Location and Competitors
Table 54. Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 55. Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 56. Alcobra SWOT Analysis
Table 57. Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 58. Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Johnson & Johnson Corporate Information, Location and Competitors
Table 60. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Major Business
Table 61. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Total Revenue (USD Million) (2017-2018)
Table 62. Johnson & Johnson SWOT Analysis
Table 63. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 64. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) by Players (2015-2020)
Table 66. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Players (2015-2020)
Table 67. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Regions (2015-2020)
Table 69. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2015-2020)
Table 70. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries (2015-2020)
Table 71. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2015-2020)
Table 74. South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries (2015-2020)
Table 77. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) by Type (2015-2020)
Table 78. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Type (2015-2020)
Table 79. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Forecast by Type (2021-2025)
Table 80. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Application (2015-2020)
Table 81. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Application (2015-2020)
Table 82. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Forecast by Application (2021-2025)
Table 83. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Picture
Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type in 2019
Figure 3. Stimulants Picture
Figure 4. Non-Stimulants Picture
Figure 5. Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Application in 2019
Figure 6. Specialty Clinics Picture
Figure 7. Hospital Picture
Figure 8. Retail Picture
Figure 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Regions in 2018
Figure 23. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 26. South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 28. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries in 2019
Figure 30. USA Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries in 2019
Figure 35. Germany Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 36. UK Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 37. France Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries in 2019
Figure 42. China Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 45. India Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 47. South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries in 2019
Figure 49. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2015-2020)
Figure 57. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Type (2015-2020)
Figure 58. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Type in 2019
Figure 59. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share Forecast by Type (2021-2025)
Figure 60. Global Stimulants Revenue Growth Rate (2015-2020)
Figure 61. Global Non-Stimulants Revenue Growth Rate (2015-2020)
Figure 62. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Application (2015-2020)
Figure 63. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Application in 2019
Figure 64. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share Forecast by Application (2021-2025)
Figure 65. Global Specialty Clinics Revenue Growth Rate (2015-2020)
Figure 66. Global Hospital Revenue Growth Rate (2015-2020)
Figure 67. Global Retail Revenue Growth Rate (2015-2020)
Figure 68. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
Figure 72. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
Figure 74. South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
脂質障害治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Lipid Disorder Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.1% in the forecast period of 2020 to 2025 and will expected to reach USD 26310 million by 2025, from USD 20740 million in 2019. The Lipid Disorde…- 睡眠障害治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Sleep Disorder Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sleep Disorder Th…
- 季節性情動障害治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Seasonal Affective Disorder Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Seasona…
- 神経障害薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Neurological Disorder Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 22730 million by 2025, from USD 19820 million in 2019. The Neurologic…
- 大うつ病性障害（MDD）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Major Depressive Disorder (MDD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Major Depress…